Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | S17 - Innovations in Neuro-oncology

Monday 04/24/23
01:00 PM - 03:00 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Neuro-oncology
A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes for question and answer with the author.
2.00 CME credits
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:12 PM EST Speaker 2023 Neuro-oncology Investigator Award: This award recognizes junior investigators who have advanced the field of neuro-oncology.
Karisa C. Schreck, MD, PhD
01:12 PM - 01:24 PM EST Speaker 2023 Neuro-oncology Scientific Award: This award recognizes an individual from any discipline and of any academic rank for a singular scientific achievement that has advanced the field of neuro-oncology.
Ingo K. Mellinghoff, MD, FACP
01:24 PM - 01:36 PM EST Abstract 003 - Identification of the cuproptosis-related gene signature associated with the tumor environment and prognosis of patients with glioblastoma multiforme (GBM)
Obada Ababneh
01:36 PM - 01:48 PM EST Abstract 004 - Pemigatinib For Previously Treated Central Nervous System Tumors With Activating FGFR Mutations or Translocations: Results From FIGHT-207
Iben Spanggaard, MD,PhD
01:48 PM - 02:00 PM EST Abstract 005 - Safety of Direct Oral Anticoagulants as Compared to Low Molecular Weight Heparin in Treating Venous Thromboembolism in Patients with Primary Brain Tumors and Brain Metastases – A Review of Literature and Meta-analysis
Surabhi Ranjan, MD
02:00 PM - 02:12 PM EST Abstract 006 - Structured Early Advanced Care Planning Outcomes for Patients with High Grade Glioma
Meredith Pescatello
02:12 PM - 02:24 PM EST Abstract 007 - The impact of hippocampal radiation dose on cognitive outcomes in older vs younger adults with brain tumors
Sara Hardy, MD
02:24 PM - 02:36 PM EST Abstract 008 - Soluble ST2 is associated with neurotoxicity following chimeric antigen receptor T-cell therapy
Elle Fietsam
02:36 PM - 02:48 PM EST Abstract 009 - Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival following Immunotherapy in Murine GBM.
Michal Nisnboym Ziv, MD
02:48 PM - 03:00 PM EST Abstract 010 - Comparison of a STIR- and T1-based radiomics model to differentiate between plexiform neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 (NF1)
Scott R. Plotkin, MD, PhD, FAAN
Faculty Disclosures
Justin T. Jordan, MD, MPH, FAAN Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Dietitians on Demand. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Harborlight Montesorri. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Navio Theragnostics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Recursion Pharmaceuticals, Inc. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CEC Oncology. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Texas Health Resources. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Children's Tumor Foundation. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BCD Meetings. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michigan State University. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akeila Bio. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has stock in Navio Theragnostics. Dr. Jordan has stock in The Doctor Lounge. An immediate family member of Dr. Jordan has stock in OldGate. Dr. Jordan has stock in Akeila Bio. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Reimbursement for potential consultant role that was aborted with Magnet Biomedicine. Dr. Jordan has a non-compensated relationship as a board member with United Council for Neurologic Subspecialties that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a board member with Neurofibromatosis Northeast that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a board member with ABA Academy that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a chair, scientific advisory board and board member with Neurofibromatosis Network that is relevant to AAN interests or activities.
Michelle Janelsins, PhD Dr. Janelsins has nothing to disclose.
Jan Drappatz, MD Dr. Drappatz has stock in Pfizer. Dr. Drappatz has stock in Vertex. Dr. Drappatz has stock in GSK. The institution of Dr. Drappatz has received research support from Servier. Dr. Drappatz has received publishing royalties from a publication relating to health care.
Nimish A. Mohile, MD, FAAN Dr. Mohile has nothing to disclose.
W. Taylor Kimberly, MD, PhD Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hyperfine Inc.. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from Biogen. The institution of Dr. Kimberly has received research support from NControl Therapeutics. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from American Heart Association. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care.
Sara Hardy, MD Dr. Hardy has received research support from the American Cancer Society.
Jordi Rodon Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Peptomyc. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kelun Pharmaceuticals/Klus Pharma. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ellipses Pharma. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Molecular Partners. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IONCTURA SA. The institution of Dr. Rodon has received research support from Blueprint Medicines. The institution of Dr. Rodon has received research support from Black Diamond Therapeutics . The institution of Dr. Rodon has received research support from Merck Sharp & Dohme. The institution of Dr. Rodon has received research support from Hummingbird. The institution of Dr. Rodon has received research support from Yingli. The institution of Dr. Rodon has received research support from Vall d'Hebron Institute of Oncology/Cancer Core Europe. The institution of Dr. Rodon has received research support from Novartis. The institution of Dr. Rodon has received research support from Spectrum Pharmaceuticals. The institution of Dr. Rodon has received research support from Symphogen. The institution of Dr. Rodon has received research support from BioAtla. The institution of Dr. Rodon has received research support from Pfizer. The institution of Dr. Rodon has received research support from GenMab. The institution of Dr. Rodon has received research support from CytomX. The institution of Dr. Rodon has received research support from Kelun-Biotech. The institution of Dr. Rodon has received research support from Takeda-Millenium. The institution of an immediate family member of Dr. Rodon has received research support from GlaxoSmithKline. The institution of Dr. Rodon has received research support from Taiho. The institution of Dr. Rodon has received research support from Roche Pharmaceuticals. The institution of Dr. Rodon has received research support from Bicycle Therapeutics. The institution of Dr. Rodon has received research support from Merus. The institution of Dr. Rodon has received research support from Curis. The institution of Dr. Rodon has received research support from Bayer. The institution of Dr. Rodon has received research support from AadiBioscience. The institution of Dr. Rodon has received research support from Nuvation. The institution of Dr. Rodon has received research support from ForeBio. The institution of Dr. Rodon has received research support from BioMed Valley Discoveries. The institution of Dr. Rodon has received research support from Loxo Oncology. The institution of Dr. Rodon has received research support from Hutchinson MediPharma. The institution of Dr. Rodon has received research support from Cellestia. The institution of Dr. Rodon has received research support from Deciphera. The institution of Dr. Rodon has received research support from Ideaya. The institution of Dr. Rodon has received research support from Amgen. The institution of Dr. Rodon has received research support from Tango Therapeutics. The institution of Dr. Rodon has received research support from Mirati. The institution of Dr. Rodon has received research support from Linnaeus Therapeutics . Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving as a Member with European Society for Medical Oncology. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving as a Advisory Committee Member with Vall d'Hebron Institute of Oncology/Ministero De Empleo Y Seguridad Social. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving as a Advisory Committee Member with Chinese University of Hong Kong . Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Boxer Capital, LLC. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Tang Advisors, LLC.
Surabhi Ranjan, MD The institution of Dr. Ranjan has received research support from Cleveland Clinic.
Frank S. Lieberman, MD The institution of Dr. Lieberman has received research support from Novocure. The institution of Dr. Lieberman has received research support from Black Diamond. The institution of Dr. Lieberman has received research support from Chimerix. The institution of Dr. Lieberman has received research support from Abbvie.
Michael T. Milano, MD,PhD Dr. Milano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Milano has received publishing royalties from a publication relating to health care.
T Kevin Hitchenes, PhD Dr. Hitchenes has nothing to disclose.
Dana Borcherding, PhD Dr. Borcherding has nothing to disclose.
Shikhar Uttam, PhD Dr. Uttam has nothing to disclose.
Yoshie A. Umemura, MD Dr. Umemura has received personal compensation for serving as an employee of Dignity Health. Dr. Umemura has received personal compensation for serving as an employee of University of Michigan. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Umemura has received research support from Gateway for Cancer Research.
Ping Chi, MD,PhD An immediate family member of Dr. Chi has stock in ORIC. The institution of Dr. Chi has received research support from NingBo NewBay Technology Development Ltd. The institution of Dr. Chi has received research support from Deciphera Pharmaceuticles. The institution of Dr. Chi has received research support from Department of Defense. The institution of Dr. Chi has received research support from National Cancer Institute. The institution of Dr. Chi has received research support from FDA/OPD. The institution of Dr. Chi has received research support from NTAP (FCS Scholar) /Bloomberg Family Foundation. An immediate family member of Dr. Chi has received intellectual property interests from a discovery or technology relating to health care.
Dhivyaa Rajasundaram, PhD Dr. Rajasundaram has nothing to disclose.
Sarah Rose Vincze, Other Miss Vincze has nothing to disclose.
Alice Hervieu No disclosure on file
Ambika Parmat Jaswal, PhD Dr. Jaswal has nothing to disclose.
Ashok Panigrahy, MD Prof. Panigrahy has nothing to disclose.
Divya Srihari Miss Srihari has nothing to disclose.
Jaishri Blakeley, MD, FAAN Dr. Blakeley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics.
Tianyu Liu Dr. Liu has nothing to disclose.
Denise Leung, MD, MS Dr. Leung has stock in Enzo Ventures (real estate). An immediate family member of Dr. Leung has stock in Enzo Ventures (real estate). The institution of Dr. Leung has received research support from NCCN/Pfizer.
Wenli Cai, PhD Dr. Cai has nothing to disclose.
Chaim T. Sneiderman Mr. Sneiderman has nothing to disclose.
Caio Max Sao Pedro Rocha Lima, MD Dr. Rocha Lima has nothing to disclose.
Raphael Augusto Correa Bastianon Santiago, MD Dr. Correa Bastianon Santiago has nothing to disclose.
Costas Lyssiotis, PhD Prof. Lyssiotis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Odyssey Therapuetics. Prof. Lyssiotis has received intellectual property interests from a discovery or technology relating to health care.
Peter De Blank, MD,Other Dr. De Blank has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Lesley May Foley, Other Ms. Foley has nothing to disclose.
Mairim Melecio-Vazquez, Other Mrs. Melecio-Vazquez has nothing to disclose.
Daniel Wahl The institution of Daniel Wahl has received research support from Sontag Foundation. The institution of Daniel Wahl has received research support from NIH. The institution of Daniel Wahl has received research support from Damon Runyon Cancer Foundation. The institution of Daniel Wahl has received research support from Ben and Catherine Ivy Foundation. Daniel Wahl has received intellectual property interests from a discovery or technology relating to health care.
Julia Cristina Jones Ms. Jones has nothing to disclose.
Deborah T. Blumenthal, MD Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Affaires Medicales. Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure Israel Ltd. Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Oncology. The institution of Dr. Blumenthal has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Merck Sharp and Dohme.
Wajd Al-Holou, MD Dr. Al-Holou has nothing to disclose.
Nirja Shah, Other Miss Shah has nothing to disclose.
OREN SAGHER, MD Dr. SAGHER has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Expert Institute. Dr. SAGHER has stock in Digital Surgery. Dr. SAGHER has received publishing royalties from a publication relating to health care.
Koren Holley Ms. Holley has nothing to disclose.
Jennifer K. Thomas, Other Ms. Thomas has nothing to disclose.
Johannes Martin Salamon, MD Dr. Salamon has nothing to disclose.
Olivia Michaels Ms. Michaels has nothing to disclose.
Theodore Lawrence Theodore Lawrence has received publishing royalties from a publication relating to health care.
Sameer Agnihotri, PhD Prof. Agnihotri has nothing to disclose.
Ian Pollack, MD Dr. Pollack has nothing to disclose.
Baoli Hu, PhD Dr. Hu has nothing to disclose.
Kathryn Elizabeth Day Ms. Day has nothing to disclose.
Matt Steensma, MD Dr. Steensma has nothing to disclose.
Brigitte Widemann Brigitte Widemann has nothing to disclose.
Michelle Kim, MD The institution of Dr. Kim has received research support from Blue Earth Diagnostics.
Lipika Goyal, MD No disclosure on file
Lauryn Hemminger Dr. Hemminger has nothing to disclose.
Angela C. Hirbe, MD,PhD Dr. Hirbe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazenica. Dr. Hirbe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. The institution of Dr. Hirbe has received research support from Tango Therapeutics. Dr. Hirbe has received intellectual property interests from a discovery or technology relating to health care.
Michal Nisnboym Michal Nisnboym has nothing to disclose.
Eva Dombi Eva Dombi has nothing to disclose.
Caron Jacobson, MD Dr. Jacobson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Kite/Gilead. Dr. Jacobson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/Celgene. Dr. Jacobson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for bluebird bio. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epizyme. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Instil Bio. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abintus Bio. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Caribou Bio. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miltenyi. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphosys. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImmPACT Bio. Dr. Jacobson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. Dr. Jacobson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Weitz and Lutz. The institution of Dr. Jacobson has received research support from Kite/Gilead. The institution of Dr. Jacobson has received research support from Pfizer.
Santosh Kesari, MD, PhD, FAAN Dr. Kesari has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for xcures. Dr. Kesari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Duke.
Christine Pratilas Christine Pratilas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Day One. The institution of Christine Pratilas has received research support from Kura Oncology. The institution of Christine Pratilas has received research support from Novartis.
Bernard Marini, Other Dr. Marini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals.
Jason Heth, MD Dr. Heth has nothing to disclose.
Larry Junck, MD Dr. Junck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Junck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Brinker Doyen . Dr. Junck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan. Dr. Junck has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gidley Sarli & Marusak. Dr. Junck has received personal compensation in the range of $500-$4,999 for serving as a Expert evaluating a complaint involving faculty member with University of Minnesota.
Miriam Bredella Miriam Bredella has nothing to disclose.
Zujian Xiong, MD,PhD Dr. Xiong has nothing to disclose.
Zachary Mulder No disclosure on file
Joe D. Latoche, Other Mr. Latoche has nothing to disclose.
Morgan McKeown Ms. McKeown has nothing to disclose.
Jessie Nedrow, PhD Dr. Nedrow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ChemImage. The institution of Dr. Nedrow has received research support from Guerbet.
Matthew Schipper Matthew Schipper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Innovative Analytics.
Michael Schaffer, PhD Dr. Schaffer has received personal compensation for serving as an employee of Incyte. Dr. Schaffer has stock in Incyte. Dr. Schaffer has stock in Johnson & Johnson.
Bethann Sayers, RN Mrs. Sayers has nothing to disclose.
ReidAnn Elizabeth Sever, Other Miss Sever has nothing to disclose.
Iben Spanggaard, MD,PhD Dr. Spanggaard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. The institution of Dr. Spanggaard has received research support from Roche. The institution of Dr. Spanggaard has received research support from Genentech. The institution of Dr. Spanggaard has received research support from Astra-Zeneca. The institution of Dr. Spanggaard has received research support from Incyte. The institution of Dr. Spanggaard has received research support from Pfizer. The institution of Dr. Spanggaard has received research support from MSD. The institution of Dr. Spanggaard has received research support from PUMA Biotechnology. The institution of Dr. Spanggaard has received research support from Orion Pharma. Dr. Spanggaard has received personal compensation in the range of $500-$4,999 for serving as a Reimbursement for travel-related expenses for the AAN2023 with Incyte.
Xin Li, PhD Dr. Li has nothing to disclose.
Gary Kohanbash, PhD The institution of Dr. Kohanbash has received research support from NIH.
Itay Raphael, PhD The institution of Dr. Raphael has received research support from Walter L. Copeland fund of The Pittsburgh foundation.
Marc Matrana, MD Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Matrana has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AstraZeneca . Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Seagen. Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Astellas . Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai . Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Exelixis . Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serano .
Matthew B. Bevers, MD, PhD Dr. Bevers has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. An immediate family member of Dr. Bevers has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hinshaw Law. An immediate family member of Dr. Bevers has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Colorado Department of Law. The institution of Dr. Bevers has received research support from NINDS. The institution of an immediate family member of Dr. Bevers has received research support from AHRQ. The institution of an immediate family member of Dr. Bevers has received research support from NIH/Kowa Industries.
Scott R. Plotkin, MD, PhD, FAAN Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Kai Pollard, Other Mrs. Pollard has received personal compensation for serving as an employee of Personal Genome Diagnostics.
Yilun Sun Yilun Sun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for international journal of radiation oncology biology physics.
Myung-Ju Ahn No disclosure on file
Caroline Booraem Ms. Booraem has nothing to disclose.
Jacqueline Marie Behr, NP Mrs. Behr has nothing to disclose.
Luisa Veronese, MD Dr. Veronese has received personal compensation for serving as an employee of Incyte. Dr. Veronese has stock in Incyte.
Carolyn J. Anderson, PhD Prof. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Prof. Anderson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Nuclear Medicine and Molecular Imaging. Prof. Anderson has stock in Lumiphore. Prof. Anderson has stock in Focus-X. The institution of Prof. Anderson has received research support from Cancer Targeted Technology.
Thomas Pearce Thomas Pearce has nothing to disclose.
Shernine Lee, Other Ms. Lee has nothing to disclose.
Natalia Oliveira, Other Mrs. Oliveira has received personal compensation for serving as an employee of Incyte. Mrs. Oliveira has stock in Incyte.
Bo Li, PhD,Other Dr. Li has nothing to disclose.
Jennifer N. Serventi, PA Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Krithika Suresh, PhD Dr. Suresh has nothing to disclose.
Crystal Burgess Ms. Burgess has nothing to disclose.
Maya Viera, Other Miss Viera has nothing to disclose.
Victor Mautner Victor Mautner has nothing to disclose.
Meredith Pescatello Mrs. Pescatello has nothing to disclose.
Asad Ali No disclosure on file
Sean Patrick Ferris, Other Dr. Ferris has nothing to disclose.
Amit Mahipal, MD Dr. Mahipal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca .
Elle Fietsam Miss Fietsam has nothing to disclose.
Maria Vieito, MD Ms. Vieito has nothing to disclose.
Ina Ly, MD An immediate family member of Dr. Ly has received personal compensation for serving as an employee of Enanta Pharmaceuticals. Dr. Ly has received research support from Department of Defense. An immediate family member of Dr. Ly has received intellectual property interests from a discovery or technology relating to health care.
Bruce R. Korf, MD Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Pharmaceuticals. Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Healx. Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Recursion. Dr. Korf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genome Medical. Dr. Korf has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Infixion. Dr. Korf has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Human Genetics. Dr. Korf has stock in Genome Medical. The institution of Dr. Korf has received research support from NIH. The institution of Dr. Korf has received research support from Department of Defense. The institution of Dr. Korf has received research support from Children's Tumor Foundation. Dr. Korf has received publishing royalties from a publication relating to health care. Dr. Korf has received publishing royalties from a publication relating to health care. Dr. Korf has received publishing royalties from a publication relating to health care.
Daniel Junhyuk Kwon, Other Mr. Kwon has nothing to disclose.
Wilson Edwards, PhD An immediate family member of Dr. Edwards has received personal compensation in the range of $0-$499 for serving as a Consultant for Lumiphore.
Demetrius Devin Boswell, Other Mr. Boswell has nothing to disclose.
Rebecca Raphael, Other Mrs. Raphael has nothing to disclose.
Ayah Al-Bzour Miss Al-Bzour has nothing to disclose.
Ghayda'a Netham Al-Majali Ms. Al-Majali has nothing to disclose.
Saja Alzghoul Miss Alzghoul has nothing to disclose.
Yaman Ahmed Mr. Ahmed has nothing to disclose.
Zaid Mohammad Khalefa Mr. Khalefa has nothing to disclose.
Karisa C. Schreck, MD, PhD Dr. Schreck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra LLC. The institution of Dr. Schreck has received research support from Springworks Therapeutics. Dr. Schreck has received personal compensation in the range of $500-$4,999 for serving as a speaker with Springworks Therapeutics.
Ingo K. Mellinghoff, MD, FACP Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Voyager Therapeutics . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Group. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Puma Biotechnology. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DC Europa Ltd. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardinal Health. Dr. Mellinghoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Mellinghoff has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASCO/JCO. The institution of Dr. Mellinghoff has received research support from Amgen. The institution of Dr. Mellinghoff has received research support from General Electric. The institution of Dr. Mellinghoff has received research support from Lilly. The institution of Dr. Mellinghoff has received research support from Kazia Therapeutics. An immediate family member of Dr. Mellinghoff has received research support from Vigeo Therapeutics. The institution of an immediate family member of Dr. Mellinghoff has received research support from Samus Therapeutics. The institution of Dr. Mellinghoff has received research support from Erasca .
Ashley P. Ghiaseddin, MD, FAAN Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neosoma. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aptitude Health. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO Pharma USA. Dr. Ghiaseddin has stock in Viatris Inc.
Alissa Ashley Thomas, MD, FAAN Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roon. The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Obada Ababneh Mr. Ababneh has nothing to disclose.
Michal Nisnboym Ziv, MD Dr. Nisnboym Ziv has nothing to disclose.